IMID Trademark

Trademark Overview


On Thursday, February 28, 2013, a trademark application was filed for IMID with the United States Patent and Trademark Office. The USPTO has given the IMID trademark a serial number of 85863284. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2016. This trademark is owned by Celgene Corporation. The IMID trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific res...

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, ...
imid

General Information


Serial Number85863284
Word MarkIMID
Filing DateThursday, February 28, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 4, 2013

Trademark Statements


Indication of Colors claimedThe color(s) orange and gold is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "IMID" in gold letters with an arrow to the right in orange.
Goods and ServicesDevelopment and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
Goods and ServicesProviding on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
Section 2(f) Limitation Statementas to "IMID"

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 19, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 19, 2013
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Tuesday, September 6, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 5, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2016EXTENSION 5 GRANTED
Monday, December 28, 2015EXTENSION 5 FILED
Monday, December 28, 2015TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 14, 2015EXTENSION 4 GRANTED
Tuesday, June 30, 2015EXTENSION 4 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 24, 2015EXTENSION 3 GRANTED
Monday, January 5, 2015EXTENSION 3 FILED
Monday, January 5, 2015TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014EXTENSION 2 GRANTED
Friday, May 23, 2014EXTENSION 2 FILED
Tuesday, June 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 23, 2014TEAS EXTENSION RECEIVED
Saturday, December 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2013EXTENSION 1 GRANTED
Thursday, December 12, 2013EXTENSION 1 FILED
Thursday, December 12, 2013TEAS EXTENSION RECEIVED
Tuesday, July 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 4, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 1, 2013ASSIGNED TO LIE
Friday, April 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 19, 2013EXAMINER'S AMENDMENT ENTERED
Friday, April 19, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2013EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 17, 2013ASSIGNED TO EXAMINER
Friday, March 8, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 4, 2013NEW APPLICATION ENTERED IN TRAM